Company Filing History:
Years Active: 2019-2025
Title: Innovations of Bruno Miguel Da Cruz Godinho
Introduction
Bruno Miguel Da Cruz Godinho is a prominent inventor based in Worcester, MA (US). He has made significant contributions to the field of therapeutic oligonucleotides, holding a total of seven patents. His work focuses on innovative solutions for treating neurodegenerative diseases.
Latest Patents
Among his latest patents is the "Dual-acting siRNA based modulation of C9orf72." This disclosure relates to novel C9ORF72 targeting sequences and provides novel sense and antisense dual-targeting oligonucleotides for the treatment of neurodegenerative diseases. Another notable patent is "Dynamic pharmacokinetic-modifying anchors," which involves therapeutic oligonucleotides comprising pharmacokinetic (PK)-modifying anchors. This patent outlines methods for treating diseases or disorders by administering a therapeutic oligonucleotide that includes one or more PK-modifying anchors.
Career Highlights
Bruno is affiliated with the University of Massachusetts, where he continues to advance his research and innovation in the field. His work has garnered attention for its potential impact on the treatment of various diseases.
Collaborations
Some of his notable coworkers include Anastasia Khvorova and Matthew Hassler, who contribute to the collaborative efforts in his research endeavors.
Conclusion
Bruno Miguel Da Cruz Godinho exemplifies the spirit of innovation in the field of therapeutic oligonucleotides. His patents and research are paving the way for new treatments in neurodegenerative diseases.